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Pharmaceutical assistance concerns actions developed by the pharmacist and other professionals with 
the purpose of promoting, protecting and restoring health. Medications are an essential tool in this 
process that focuses on the access to, and the rational use of, drugs. This study is aimed at evaluating the 
Pharmaceutical Assistance provided by Municipal Health Offices in the Taquari Valley, Rio Grande do 
Sul. For this purpose, 2,794 users of public pharmacies were interviewed and data was analyzed using 
descriptive statistics. The users of the public pharmacies were mainly female and individuals with low 
educational level and income. On average, 2.41 drugs were prescribed per medical prescription and 
1.72 of these were procured. Out of the total medicines prescribed, 76.5% were listed in the municipal 
standard drug list (SDL). Medication was prescribed by its generic name in 81.8% of the prescriptions. 
Antibiotics and injections were prescribed in 11.9% and 4.0% of the prescriptions, respectively. Users’ 
access to information is partial, which can impair adherence to the treatment. Thus, it is possible to 
conclude that review of the service is necessary for it to be effective. 
Uniterms: Pharmaceutical assistance. Unified Health System. Medicines/rational use. Medicines/
prescription indicators.
A Assistência Farmacêutica se preocupa com ações desenvolvidas pelo farmacêutico ou outros profissionais 
com o propósito de promover, proteger e restaurar a saúde. Medicamentos são ferramentas essenciais nesse 
processo, que se concentra no acesso e no uso racional de fármacos. Este estudo objetivou a avaliação da 
Assitência Farmacêutica suprida pela Secretaria Municipal da Saúde no Vale do Taquari, no Rio Grande 
do Sul. Com esse propósito, 2.794 usuários das farmácias públicas foram entrevistados e analisaram-se os 
dados usando estatística descritiva. Os usuários das farmácias públicas eram, principalmente, mulheres e 
indivíduos com baixo nível educacional e financeiro. Na média, 2,41 fármacos eram prescritos por prescrição 
médica e 1,72 destes foram obtidos. Do total de medicamentos prescritos, 76,5% estava inscritos na lista 
de medicamentos padrão do município (SDL). A medicação foi prescrita pelo nome genérico em 81,8% 
dos casos. Antibióticos e injeções foram prescritas em 11,9% e 4,0% das prescrições, respectivamente. O 
acesso dos usuários à informação é parcial, o que pode prejudicar a adesão ao tratamento. Dessa forma, é 
possível concluir que a revisão do serviço é necessária para que seja eficaz. 
Unitermos: Assistência farmacêutica. Sistema Único de Saúde. Medicamentos/uso racional. 
Medicamentos/indicadores de prescrição.
INTRODUCTION
The network of primary health care units, to which 
the municipal public pharmacies belong, account for the 
locations where most of the population seeks assistance 
(66.5%) (Ribeiro et al., 2006). Therefore, a structured 
service of pharmaceutical assistance in these facilities is 
essential in ensuring access to medication and informa-
tion, while contributing to an increase in health quality 
standards of the population.
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The Unified Health System (SUS) ensures access to 
medication based on the patient’s rights to full execution of 
therapeutic assistance, including pharmaceutical assistance 
(Brazil, 1990). The latter is defined as “the group of activi-
ties related to medication, aimed at supporting the health 
practices required by a community. It involves medication 
provision, storage and quality control, therapeutic safety 
and efficacy of the medication, follow-up and assessment 
of its use, the acquisition and dissemination of information 
about medication, and the constant education of health 
care professionals, patients and the community in order to 
guarantee the rational use of medication.” (Brasil, 1998).
In a bid to achieve qualification of primary health 
care, the National Policy of Pharmaceutical Assistance was 
instituted, by means of Resolution No. 338 (May 6, 2004), 
aimed at ensuring the principles of universality, equity and 
integrality, a constituent part of the National Health Policy. 
In this context, the objective of Pharmaceutical Assistance 
is ensuring the availability and rational use of medication 
as a tool to achieve universality, equity and integrality in 
the Unified Health System (SUS).
Medication has a relevant role in the restoration and 
maintenance of health (Girotto, Silva, 2006), whereby its 
rational use contributes to the quality of health services. 
On the other hand, its inappropriate or unadvised use may 
harm the user as well as society.
The counseling provided to the patient when me-
dication is dispensed by the pharmacist is essential to 
promote its rational use and overall treatment. Research 
has demonstrated that patients are widely receptive to 
pharmaceutical counseling (Paulo, Zanini, 1997; Rantucci, 
1998). The role of the pharmacist in the Pharmaceutical 
Assistance includes (besides guidance and education on 
health) the selection, supply schedule, purchase, storage, 
distribution and usage of medications (Brasil, 2001). 
The assessment of Pharmaceutical Assistance qua-
lity allows the generation of data that may contribute to 
optimizing the investment of generally scarce financial re-
sources. Furthermore, the gathered data may serve to guide 
actions resulting in the prevention of problems related to 
pharmacotherapy, thus reducing the number of medical 
appointments derived from the prescribing cascade (Ro-
chon, Gurwitz, 1997). The appropriate implementation of 
this assessment will provide information that may support 
the restructuring and qualification of services performed 
by the health system, leading to an increase in patients’ 
quality of life, as well as contributing to the knowledge 
of rational use of medications. Hence, this study aimed to 
evaluate the Pharmaceutical Assistance provided by Mu-
nicipal Health Offices in the Taquari Valley, Rio Grande 
do Sul State.
MATERIAL AND METHODS
This study is part of the research project called Eva-
luation of the Pharmaceutical Assistance in the Unified 
Health System (SUS) in the Taquari Valley, Rio Grande 
do Sul State, a population-based cross-sectional study in-
tended to better understand the structure of Pharmaceutical 
Assistance in the cities that constitute the Taquari Valley, 
as well as its interface with the system users.
Taquari Valley is comprised of 36 cities, located in 
the central area of the state of Rio Grande do Sul, with 
a total population of 316,714 inhabitants (BDR, 2008). 
The target population of the study was users of public 
pharmacies in these cities. The number of participants 
was established by the saturation sampling process. This 
means of determining the sample size is based on obser-
vation of repetition in the obtained answers, i.e., up to the 
point where collected data no longer presents variety for 
the subject on which the research is focused. Thus, the 
sample size is determined by the researcher, who evaluates 
the relevance of proceeding with the collection of data. 
(Bauer, Gaskell, 2002). 
The following criteria were used for screening the 
participants for inclusion in this study: 18 years of age 
or older, approached immediately after being assisted 
at the pharmacy (regardless of whether or not they had 
access to the medication), and their willingness to take 
part in the study. Criteria for exclusion included the 
following: refusal from the administrator to include their 
city in the research; failure of the city administration to 
provide the required information (REMUME list); or the 
unwillingness of the user to participate in the study. The 
gathering of data was conducted from January through 
October, 2007.
A structured, pre-codified and previously tested 
three-part questionnaire was used to conduct the data 
collection. The first part included information related 
to the profile of the public pharmacy user: gender, age, 
family income, occupation and frequency of service use. 
The second involved information regarding the medical 
prescription: number of drugs per prescription, and how 
many of these were obtained through the Primary Health 
Care Unit. The third part of the questionnaire consisted 
of questions related to the information received about the 
prescribed medication: what medication was prescribed, 
its indication, dosage, storage instructions, adverse reac-
tions and other information regarding its rational use (such 
as non-supervised discontinuation of treatment, access to 
documentation, doubts about the medication, indication 
of non-pharmacological treatment and procedure in case 
of medication leftover).
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To evaluate access to medication, municipal Stan-
dardized Drug Lists (SDL) were used. The prescribing 
indicators recommended by the World Health Organiza-
tion (WHO) (1993) were also applied: mean number of 
medications per prescription, percentage of medications 
prescribed with their generic names, percentage of medi-
cations from the SDL, and percentage of antibiotics and 
injection drugs prescribed.
To evaluate patient awareness about the prescribed 
medications, the following ratings were considered: awa-
re, partially aware or unaware. For each variable concer-
ning awareness (indication, time for the medication to take 
effect and dosage) the whole of prescribed medications for 
each user was assessed. Thus, in the event that patients 
knew the variables for all the prescribed medications, he 
or she was rated as aware. In cases where the patient knew 
the variables for part of the prescribed medications, he or 
she was rated as partially aware and when the patient did 
not know the variables for any of the medications, he or 
she was rated as unaware.
The gathering of data was performed by a trained 
and supervised team, composed of twelve pharmacy and 
nursing students from the UNIVATES University Center.
The data were analyzed by the program EPI-INFO 
(version 3.3.2, 2005) and by the program SPSS (version 
8.0, 1998). The data analysis plan included a descriptive 
analysis by means of frequency distribution for the va-
riables and their stratification according to the size of the 
city examined. The cities were divided into four groups 
regarding their population: cities with fewer than 10,000 
inhabitants, 10,000 to 19,999 inhabitants, 20,000 to 29,999 
inhabitants, and cities with more than 30,000 inhabitants.
In order to ensure confidentiality, minimum risk and 
discomfort as well as the maximization of benefits, all the 
users who agreed to participate in the study signed the 
Term of Free and Informed Consent (TFIC). The protocol 
complied with the conditions established by Resolution 
196/96 of the National Health Council (NHC) and was 
approved by the Ethics Committee of the UNIVATES 
University Center (Resolution COEP no. 17/2006).
RESULTS
Sample characterization
Taquari Valley consists of 36 cities; 28 having parti-
cipated in the research, three having expressed refusal to 
participate, and five having been excluded from the study 
for failure to supply the municipal Standardized Drug List. 
In order to simplify the analysis, the cities were grouped 
according to their population, so that 21 cities (n= 765 
users) formed the population group with fewer than 10,000 
inhabitants. Three cities (n= 517 users) comprised the 
group with population between 10,000 and 19,999 inha-
bitants, three cities (n=848 users) formed the group with 
population between 20,000 and 29,999 inhabitants, and 
one city had a population of more than 30,000 inhabitants 
(n=664 users). Nevertheless, it is important to highlight 
the fact that among the analyzed cities, only six (21.4%) 
had a professional pharmacist running the pharmacy of 
the Primary Health Care Unit.
Socio-demographic profile of users
The variables analyzed were gender, age group, edu-
cational level, household income, occupation, and housing 
(rural or urban areas). Table 1 presents the overall data, 
including the valley and city groups.
Within the analyzed population sample, there is a 
prevalence of women (67.1%), individuals under 50 years 
of age (54.1%) and people with incomplete elementary 
education (63.1%). These characteristics are consistent 
with those observed in other studies conducted among 
users of the Unified Health System - SUS (Colombo et 
al., 2004; Ribeiro et al, 2006; Paniz et al., 2008). In addi-
tion, this population lives predominantly in urban areas 
(75.4%).
Regarding users’ occupation, it was observed that 
most of this population is out of the job market (62.3%), 
namely retirees or welfare beneficiaries, unemployed 
workers and other individuals who do not have an activity 
outside the household. However, it is important to draw 
attention to the fact that only 23.8% of the population 
analyzed is engaged in the formal job market. Another 
peculiar characteristic is the prevalence of retirees and 
welfare beneficiaries (40.8%) in cities with fewer than 
10,000 inhabitants and the consequent lower number of 
individuals engaged in the formal job market (15.0%), 
which can be explained by the concentration of job op-
portunities in the central cities of the Valley. The monthly 
household income of most of this population is up to three 
minimum wages (82.5%).
Access to medication
The number of medications per prescription ranged 
from 1-12, with a mean number of 2.41 drugs per medical 
prescription. On average, every patient had access to 1.72 
medications (0 to 12) with regard to their prescription 
(Table II). The majority of the users (59.2%) had their 
prescription needs completely met by the municipal phar-
macies, whereas 27.9% of the users had their prescriptions 
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partially supplied. Only 12.9% of the patients did not 
have access to any of their prescribed medications at the 
municipal pharmacies. (Table II).
The prescriptions for these patients were assessed 
according to criteria of the WHO, thus 76.5% of the dru-
gs prescribed were part of the Municipal Standardized 
Dug List (SDL) of the analyzed cities (ranging between 
72.4% and 82.2%). The use of generic brands occurred 
in the prescription of 81.8% of the medications, varying 
between 73.4 and 90.4% among the evaluated city groups. 
Antibiotics were found in 11.9% of the prescriptions, va-
rying between 8.1 and 18.6% depending on the city group 
analyzed. Prescriptions for injection drugs were issued to 
4.0% of the users, varying between 1.7 and 6.4% among 
the city groups (Table II).
Considering access to medication, it was found that 
in most cases (90.9%), the medications supplied to users 
from the study sample were part of the municipal SDL. 
TABLE I – Socio-demographic profile of users of Pharmacies within the Primary Health Care Units (UBS) in the Taquari Valley – 
RS State (N = 2794 – Taquari Valley)
VARIABLES POPULATION (inhabitants) TAQUARI
VALLEY< 10,000 10,000-19,999 20,000-29,999 >30,000
GENDER Male 37.0% 32.9% 31.7% 29.8% 32.9%
Female 63.0% 67.1% 68.3% 70.2% 67.1%
AGE GROUP 
(years)
<20 16.8% 7.2% 17.8% 17.3% 15.4%
21-30 9.7% 11.0% 11.7% 10.1% 10.6%
31-40 10.0% 12.0% 11.5% 14.0% 11.7%
41-50 11.8% 20.7% 16.5% 18.2% 16.4%
51-60 17.3% 19.5% 19.1% 17.6% 18.3%
61-70 19.5% 17.2% 15.3% 13.9% 16.5%
>71 14.9% 12.4% 8.1% 8.9% 11.1%
EDUCATIONAL 
LEVEL 
Illiterate 6.8% 2.5% 6.5% 5.7% 5.7%
Incomplete elementary education 67.2% 71.0% 58.4% 58.4% 63.1%
Complete elementary education 7.1% 4.4% 6.5% 8.4% 6.7%
Incomplete secondary education 2.6% 5.0% 7.7% 5.1% 5.2%
High school diploma 7,3% 11.0% 9.3% 10.7% 9.4%
Incomplete college 0.8% 0.8% 1.2% 0.9% 0.9%
College degree 1.0% 1.0% 0.6% 1.1% 0.9%
Does not know/has not answered 7.2% 4,3% 9.8% 9.7% 8.1%
OCCUPATION Formal employment 15.0% 29.8% 22.9% 31.1% 23.8%
Informal employment 22.9% 11.5% 13.1% 6.1% 13.9%
Unemployed 1.0% 1.9% 3.3% 4.5% 2.7%
Does not work 20.3% 23.2% 31.7% 34.0% 27.6%
Retired or welfare beneficiary 40.8% 33.6% 29.0% 24.3% 32.0%
HOUSEHOLD 
INCOME 
PER MONTH* 
< 1 minimum wage 6.4% 2.3% 4.6% 3.6% 4.2%
1 - 3 minimum wages 77.3% 77.6% 81.7% 76.5% 78.3%
4 - 5 minimum wages 12.9% 14.5% 9.4% 15.4% 13.1%
6 - 10 minimum wages 2.2% 4.1% 1.8% 2.6% 2.7%
> 10 minimum wages 0.3% 0.2% 0.8% 0.8% 0.5%
Does not know/has not answered 0.9% 1.3% 1.7% 1.1% 1.2%
HOUSING Rural area 57.5% 29.0% 13.3% 0.9% 25.4%
Urban area 42.5% 71.0% 86.7% 99.1% 74.6%
* national minimum wage (equivalent to R$ 350.00 when research was conducted)
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However, in cases of inaccessibility, it was found that 
50.4% of the medications were part of the SDL (Table II). 
The users reported that, in cases where the medication was 
not available at the UBS pharmacy, they either purchased 
it (87.1%), awaited the medication stock replenishment 
(2.7%), did not use the medication (4.6%) or took other 
measures (5.6%).
The prescribed medications overall are continuous-
use drugs (62.6%). In the analyzed cities, the distribution 
of medication for treatment of chronic diseases was for a 
30-day period. These data therefore support the findings 
that 69.3% of the population of the study returns to the 
UBS Pharmacy at least once a month, whereas the re-
maining users do so less often, or only when necessary 
(30.7%). 
Access to information
Most of the users reported being given information 
about the medications (70.7%) and reported having no 
doubts (91.3%). When questioned about the information 
obtained, the users reported that it concerned dosage 
(68.2%), indication (12.2%), indication and dosage 
(11.4%), adverse reactions (2.4%), importance of treat-
ment engagement (2.3%), or other (3.5%). However, the 
vast majority of the population analyzed reported neither 
obtaining information about storage of the medications 
(73.4%), nor having received information documentation 
(87.5%) (Table III).
The small proportion of the analyzed population that 
mentioned having doubts or concerns, reported that these 
were related to the efficacy of the medications (19.4%), 
their safety (43.9%), the lack of access to the medication 
(10.1%), the difference between generic and brand-name 
drugs (2.9%) or other (23.7%).
Patient awareness about medication was assessed 
and the results are presented in Table IV. The sample po-
pulation, overall, was aware of the indication (81.1%) and 
dosage (81.7%) of the prescribed medications. However, 
only a minority of users were aware of the time it takes 
for the medication to take effect (1.1%). The study also 
found that 54.5% of the users store the medications in 
inappropriate locations.
The study also shows that 42.8% of the users re-
ported that there was no leftover medication. However, 
other users mentioned keeping the remaining medication 
(21.2%), returning it to the pharmacy (23.2%), donating it 
to other people (0.5%) or discarding it (12.3%).
TABLE II – Assessment of prescribing indicators recommended by WHO in prescriptions supplied at Pharmacies within the Primary 
Health Care Units (UBS) in the Taquari Valley – RS State (N = 2794 – Taquari Valley)
 
VARIABLES POPULATION (inhabitants) TAQUARI 
VALLEY< 10,000 10,000-19,999 20,000-29,999 >30,000
Mean number of medications per prescription 2.54 2.33 2.48 2.25 2.41 
Percentage of medications prescribed from the 
municipal Standard Drug List (SDL)
72.4% 82.2% 76.5% 77.2% 76.5% 
Percentage of medications prescribed with their 
generic names (Common Brazilian Denomination) 
79.9% 80.2% 73.4% 90.4% 81.8%
Percentage of antibiotics 11.4% 8.1% 18.6% 9.6% 11.9%
Percentage of injection drugs 3.8% 3.9% 6.4% 1.7% 4.0%
Mean number of medications obtained 1.89 1.56 1.68 1.67 1.72
Percentage of medications obtained from the 
municipal SDL
92.3% 92.3% 86.7% 92.9% 90.9%
Percentage of medications obtained that are not 
part of the municipal SDL
7.7% 7.7% 13.3% 7.1% 9.1%
Percentage of missing medications from the 
municipal SDL
44.7% 65.6% 56.6% 32.1% 50.4%
Percentage of missing medications that are not part 
of the municipal SDL
55.3% 34.4% 43.4% 67.9% 49.6%
Access Total 62.8% 54.4% 56.3% 62.5% 59.2%
Partial 28.6% 25.9% 30.3% 25.6% 27.9%
None 8.6% 19.7% 13.4% 11.9% 12.9%
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Most users (95.2%) believed it was important to use 
the medication. However, 14.9% of the population stu-
died reported interrupting the treatment without medical 
supervision.
DISCUSSION
In the Taquari Valley, despite the fact that 59.2% of 
the population has access to the medication, there are dis-
crepancies between the prescribed and standardized drugs 
(part of the municipal standard drug lists). In addition, the-
re is some lack of patient awareness of pharmacotherapy. 
These findings, therefore, are factors that may compromise 
the rational use of medication. 
Paniz et al (2008), assisted by the Project for Expan-
sion and Consolidation of the Family Health, conducted a 
study that included adults (aged 30-64 years) and elderly 
(aged 65 years or more) in the South and Northeast regions 
of Brazil. This study about access to continuous-use medi-
cation for treatment of diabetes, high blood pressure and/or 
mental illnesses, found total access was observed in 81.2% 
of the cases, whereas partial access corresponded to 7.0% 
and no access was observed in 11.8% of the cases. In the 
Taquari Valley study, the users with total access corres-
ponded to 59.2% of the sample. This lower score may be 
related to the way data were gathered, not limiting access 
to specific groups. In addition, Paniz et al conducted their 
study in areas assisted by the Family Health Program, 
therefore the areas had a higher level of social assistance.
Table IV presents data from studies conducted in 
Brazil assessing prescriptions according to the prescribing 
indicators recommended by the World Health Organiza-
TABLE III – Access to information about prescribed medications among users of Pharmacies within the UBS in the Taquari Valley, 
RS State (N = 2794 – Taquari Valley)
VARIABLES POPULATION (inhabitants) TAQUARI 
VALLEY< 10000 10000-19999 20000-29999 >30000
Information about the medications YES 68.4% 83.2% 75.5% 57.5% 70.7%
NO 31.6% 16.8% 24.5% 42.5% 29.3%
Information about storage of 
medications
YES 31.1% 17.0% 21.9% 34.6% 26.6%
NO 68.9% 83.0% 78.1% 65.4% 73.4%
Access to documentation YES 24.3% 11.0% 6.5% 7.8% 12.5%
NO 75.7% 89.0% 93.5% 92.2% 87.5%
Doubts or concerns YES 9.4% 5.6% 11.0% 7.2% 8.7%
NO 90.6% 94.4% 89.0% 92.8% 91.3%
TABLE IV - Assessment of patient awareness of prescribed medications among users of pharmacies within the Primary Health Care 
Units (UBS) in the Taquari Valley – RS State (N = 2794 – Taquari Valley)
      
VARIABLES POPULATION (inhabitants) TAQUARI 
VALLEY< 10000 10000-19999 20000-29999 >30000
INDICATION aware 88.0% 84.7% 72.5% 81.3% 81.1%
partially aware 8.5% 8.5% 20.8% 9.8% 12.5%
unaware 3.5% 6.8% 6.7% 8.9% 6.4%
TIME FOR DRUG TO 
TAKE EFFECT
aware 0.5% 2.1% 0.7% 1.4% 1.1%
partially aware 0.3% 4.3% 4.1% 3.8% 3.0%
unaware 99.2% 93.6% 95.2% 94.8% 95.9%
DOSAGE aware 77.8% 95.6% 83.1% 73.6% 81.7%
partially aware 18.8% 1.5% 13.3% 19.1% 14.0%
unaware 3.4% 2.9% 3.6% 7.3% 4.3%
STORAGE appropriate 49.0% 45.9% 46.2% 40.2% 45.5%
inappropriate 51.0% 54.1% 53.8% 59.8% 54.5%
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tion (WHO). In the Taquari Valley, the mean number of 
prescribed drugs (2.41) was higher than that recommended 
by the WHO and the findings of other studies (Colombo 
et al., 2004; Santos, Nitrini, 2004; Brasil, 2005; Naves, 
Silver, 2005; Girotto, Silva, 2006; Farias et al., 2007). 
The percentage of prescribed medications that are part 
of the municipal SDL in the area (76.5%) exceeded the 
recommendations of the WHO. However, the figure was 
lower than the findings for other Brazilian regions in these 
other studies. Generic drug names were used in 81.8% of 
the analyzed prescriptions. This finding, although not ideal 
since legal recommendations are for 100% generic names 
in prescriptions within the primary health care facilities, 
is higher than the level observed in other Brazilian studies 
(Santos, Nitrini, 2004; Naves, Silver, 2005; Girotto, Silva, 
2006), except those conducted by the Pan American Health 
Organization/World Health Organization (PAHO/WHO) 
(Brasil, 2005) and by Farias et al. (2007). 
The proportion of antibiotics per prescription in the 
Taquari Valley (11.9%) was lower than the WHO limit 
rate and lower than results found in other studies (Santos, 
Nitrini, 2004; Brazil, 2005; Naves, Silver, 2005; Girotto, 
Silva, 2006; Farias et al, 2007), with the exception of rese-
arch performed in Blumenau, Santa Catarina, by Colombo 
et al (2004). In their study, the percentage corresponded 
to 12.5%, a similar score to that observed in the Taquari 
Valley. The percentage of injection drugs per prescription 
within the analyzed region, as observed in the other stu-
dies was lower than that established by the World Health 
Organization.
Consequently, it can be reported that the quality of 
analyzed prescriptions, and the levels of injection drugs 
and antibiotics are within reasonable limits, thus contri-
buting to the rational use of medication. However, some 
lack of access was found regarding the prescription of 
items from the municipal standard drug lists, and some 
non-compliance with the current legislation on use of the 
Common Brazilian Denomination (CBD) for prescriptions 
issued within the Unified Health System.
Comparison of the city groups of the Taquari Valley, 
reveals differences concerning the access to medication 
variables (percentage of prescribed medications from the 
municipal Standard Drug List (SDL), and missing medi-
cations per prescription). Colombo et al concluded that 
one of the possible causes for lack of access was related 
to the standardization of medication. In other words, the 
prescribed medications were not part of the municipal SDL 
of the analyzed city.
In cities with fewer than 10,000 inhabitants, a lower 
score for prescribed medications from the SDL can be 
observed (72.4%). However, 92.3% of the obtained me-
dication was part of the SDL. It is interesting to point out 
that only 7.7% of the unavailable medication was listed 
in the SDL. However, as a result of this inadequacy of the 
municipal SDL, it is observed that 55.3% of the missing 
medications were not part of this list. This reinforces the 
importance for each city of prescribing medications accor-
ding to the current standardization, thus ensuring access 
to safe and efficient medications.
In cities with population between 10,000 and 19,999 
inhabitants, a higher score of prescribed medications from 
the municipal SDL was found (82.2%) with a consequent 
lower score of missing medications that are not part of the 
SDL (34.4%). This inaccessibility cannot be attributed to 
TABLE V - Assessment of prescribing indicators recommended by the WHO in studies conducted in Brazil    
    
VARIABLES WHO Colombo 
et al., 
2004
Santos and 
Nitrini, 
2004
Brasil, 
2005
Naves and 
Silver, 
2005
Girotto 
and Silva, 
2006
Farias et 
al., 
2007
TAQUARI
VALLEY
Mean number of medications 
per prescription
2.0 
or less
1.8 2.2 2.3 2.3 2.0 1.5 2.41
Percentage of medications prescribed 
from the municipal SDL
70% 82.4% 83.4% 78.3% 85.3% 58.4% 91.9% 76.5%
Percentage of medications prescribed 
with generic names (CBD) 
100%* not 
collected 
data
30.6% 84.2% 73.2% 70.2% 84.2% 81.8%
Percentage of antibiotics 20% 
or less
12.5% 21.3% 40.1% 26.4% 22.0% 21.1% 11.9%
Percentage of injection drugs 10% 
or less
8.1% 8.3% 7.9% 7.5% 7.0% 1.1% 4.0%
* Mandated by Brazilian legislation (Brazil, 1999). SOURCE: adapted from Farias et al., 2007.
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drug standardization alone, but also to other aspects related 
to the Pharmaceutical Assistance cycle, such as supply 
schedule and acquisition.
The cities with populations ranging between 20,000 
and 29,999 inhabitants, on the other hand, are characteri-
zed by a higher percentage of obtained medications that 
are not in the municipal SDL (13.3%) and a significant 
percentage of missing medications that belong to the 
list (56.6%). These data point to a discrepancy between 
prescription, standardization and acquisition, given the 
fact that medications not part of the SDL are prescribed 
and therefore supplied, to the detriment of those that are 
standardized yet not available at the Primary Health Units.
In the one city with a population of more than 
30,000 inhabitants, 77.2% of the prescribed medications 
and 92.9% of the obtained medications were part of the 
municipal SDL. Furthermore, this group is notable for 
displaying the lowest score of missing standardized me-
dications (32.1%). These findings allow us to infer that the 
observance of the municipal SDL increases the probability 
of access to medication. However, other steps in the cycle 
must be observed in order to ensure full pharmacotherapy 
to the user.
In relation to patient awareness about prescribed 
medication, the need for safe storage information is evi-
dent, since medication was being stored in inappropriate 
locations by 54.5% of the sample. It is also apparent that 
clear indication and dosage information was lacking for 
18.9% and 18.3% of the users, respectively. These findings 
could be related to the fact that 73.4% of the sample did 
not have access to storage information, while 87.5% did 
not have access to explanatory documentation. Moreover, 
considering that 62.6% of the prescribed medications were 
continuous-use drugs, lack of patient awareness about 
correct storage (as well as indication, dosage and time for 
the drug to take effect), suggests flaws in the prescription 
and medication dispensing processes.
According to Silva et al. (2000), the absence of in-
formation constitutes one of the main reasons why 30% 
to 50% of patients do not use medications according to 
the prescription, and why many patients interrupt the tre-
atment once they feel better. As spontaneously reported, 
14.9% of the sample population admitted to interrupting 
the treatment without supervision, which may be a con-
sequence of the previously mentioned procedural flaws.
Furthermore, it is important to stress that, among 
users who obtained information about their medication, 
only 2.4% were informed of potential adverse drug reac-
tions (ADR). In addition, of the users who reported having 
doubts about pharmacotherapy, 43.9% were concerned 
about ADR. This information gap may cause the pres-
cribing cascade, where the patient does not acknowledge 
their symptom as a probable ADR, seeks further medical 
assistance and gets a new prescription, thus being unne-
cessarily exposed to a new pharmacotherapy that might 
cause other ADRs.
Given the fact that most of the sampled population 
made use of continuous-use drugs, the lack of awareness 
of the previously mentioned concerns may cause problems 
in the pharmacotherapy. Moreover, the cohort that does not 
get their medication at the Municipal Pharmacies has a low 
household income, which hinders treatment engagement. 
Ultimately, in order that medication can have a rational use, 
and to ensure access, the patient needs to be educated about 
its use. This requires the involvement of city administrators, 
prescribing physicians, individuals in charge of medica-
tion dispensing processes as well as users of the Primary 
Health Care System. Therefore, this allows us to conclude 
that review of this service is vital, and that this action must 
involve health care workers and city administrators with a 
main goal being the training of Pharmaceutical Assistance 
to promote the rational use of medication.
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